September 2023

Rheumatic diseasesBelimumab (Lympho-Stat-B, Benlysta GlaxoSmithKline Plc, London, United kingdom), a monoclonal antibodyRheumatic diseasesBelimumab (Lympho-Stat-B, Benlysta GlaxoSmithKline Plc, London, United kingdom), a monoclonal antibody towards BAFF, has not long ago been…